{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:13:32Z","timestamp":1769580812267,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","award":["ITS\/116\/19"],"award-info":[{"award-number":["ITS\/116\/19"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["08191066"],"award-info":[{"award-number":["08191066"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006355","name":"Shun Hing Institute of Advanced Engineering","doi-asserted-by":"publisher","award":["BME-p5-20"],"award-info":[{"award-number":["BME-p5-20"]}],"id":[{"id":"10.13039\/501100006355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Critical limb ischemia (CLI) is the most severe form of peripheral artery disease and exhibits a high risk of lower extremity amputations. As even the most promising experimental approaches based on mesenchymal stem cells (MSCs) demonstrated only moderate therapeutic effects, we hypothesized that other cell types with intrinsic roles in angiogenesis may exhibit a stronger therapeutic potential. We have previously established a protocol to source human peripheral blood-derived angiogenic cells (BDACs). These cells promoted revascularization and took perivascular location at sites of angiogenesis, thus resembling hematopoietic pericytes, which were only described in vivo so far. We thus hypothesized that BDACs might have a superior ability to promote revascularization and rescue the affected limb in CLI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>As standard BDAC sourcing techniques involve the use of animal-derived serum, we sought to establish a xeno- and\/or serum-free protocol. Next, BDACs or MSCs were injected intramuscularly following the ligation of the iliac artery in a murine model. Their ability to enhance revascularization, impair necrosis and modulate inflammatory processes in the affected limb was investigated. Lastly, the secretomes of both cell types were compared to find potential indications for the observed differences in angiogenic potential.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From the various commercial media tested, one xeno-free medium enabled the derivation of cells that resembled functional BDACs in comparable numbers. When applied to a murine model of CLI, both cell types enhanced limb reperfusion and reduced necrosis, with BDACs being twice as effective as MSCs. This was also reflected in histological evaluation, where BDAC-treated animals exhibited the least muscle tissue degeneration. The BDAC secretome was enriched in a larger number of proteins with pro-angiogenic and anti-inflammatory properties, suggesting that the combination of those factors may be responsible for the superior therapeutic effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Functional BDACs can be sourced under xeno-free conditions paving the way for their safe clinical application. Since BDACs are derived from an easily accessible and renewable tissue, can be sourced in clinically relevant numbers and time frame and exceeded traditional MSCs in their therapeutic potential, they may represent an advantageous cell type for the treatment of CLI and other ischemic diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-022-03095-5","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T06:02:45Z","timestamp":1660370565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia"],"prefix":"10.1186","volume":"13","author":[{"given":"Christy Wing Tung","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apurva","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Wah","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hon Fai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9878-3781","authenticated-orcid":false,"given":"Anna","family":"Blocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"3095_CR1","doi-asserted-by":"publisher","unstructured":"Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509\u201326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303849. Erratum in: Circ Res. 2015;117(1):e12.","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"3095_CR2","first-page":"80","volume":"18","author":"RA Lookstein","year":"2019","unstructured":"Lookstein RA, Zeller T, Miller LE, Driver VR, et al. Critical limb ischemia: a threat to life and limb. Endovasc Today. 2019;18:80\u20132.","journal-title":"Endovasc Today"},{"key":"3095_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/VHRM.S125065","volume":"14","author":"L Uccioli","year":"2018","unstructured":"Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag. 2018;14:63\u201374.","journal-title":"Vasc Health Risk Manag"},{"key":"3095_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1358863X15597877","volume":"20","author":"MR Jaff","year":"2015","unstructured":"Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). Vasc Med. 2015;20:465\u201378.","journal-title":"Vasc Med"},{"key":"3095_CR5","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S1078-5884(11)60014-2","volume":"42","author":"C Setacci","year":"2011","unstructured":"Setacci C, De Donato G, Teraa M, Moll FL, Ricco JB, Becker F, et al. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42:S43-59.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3095_CR6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","volume":"128","author":"JA Beckman","year":"2021","unstructured":"Beckman JA, Schneider PA, Conte MS. Advances in revascularization for peripheral artery disease: revascularization in PAD. Circ Res. 2021;128:1885\u2013912. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318261.","journal-title":"Circ Res"},{"key":"3095_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/stem.2751","volume":"36","author":"M Qadura","year":"2018","unstructured":"Qadura M, Terenzi DC, Verma S, Al-Omran M, Hess DA. Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies. Stem Cells. 2018;36:161\u201371. https:\/\/doi.org\/10.1002\/stem.2751.","journal-title":"Stem Cells"},{"key":"3095_CR8","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1016\/j.jvs.2010.01.074","volume":"51","author":"AW Bradbury","year":"2010","unstructured":"Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010;51:18S-31S. https:\/\/doi.org\/10.1016\/j.jvs.2010.01.074.","journal-title":"J Vasc Surg"},{"key":"3095_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.03.015","author":"T Sp\u00e4ter","year":"2022","unstructured":"Sp\u00e4ter T, Assun\u00e7\u00e3o M, Lit KK, Gong G, Wang X, Chen Y-Y, et al. Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis. Bioact Mater. 2022. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.03.015.","journal-title":"Bioact Mater"},{"key":"3095_CR10","doi-asserted-by":"publisher","first-page":"2100024","DOI":"10.1002\/adhm.202100024","volume":"10","author":"CE Chiang","year":"2021","unstructured":"Chiang CE, Fang YQ, Ho CT, Assun\u00e7\u00e3o M, Lin SJ, Wang YC, et al. Bioactive decellularized extracellular matrix derived from 3D stem cell spheroids under macromolecular crowding serves as a scaffold for tissue engineering. Adv Healthc Mater. 2021;10:2100024.","journal-title":"Adv Healthc Mater"},{"key":"3095_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21238999","volume":"21","author":"F Jaluvka","year":"2020","unstructured":"Jaluvka F, Ihnat P, Madaric J, Vrtkova A, Janosek J, Prochazka V. Current status of cell-based therapy in patients with critical limb ischemia. Int J Mol Sci. 2020;21:1\u201315.","journal-title":"Int J Mol Sci"},{"key":"3095_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02330-9","volume":"12","author":"C Thej","year":"2021","unstructured":"Thej C, Balasubramanian S, Rengasamy M, Walvekar A, Swamynathan P, Raj SS, et al. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia. Stem Cell Res Ther. 2021;12:1\u201316.","journal-title":"Stem Cell Res Ther"},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0126-x","volume":"6","author":"J Qin","year":"2015","unstructured":"Qin J, Yuan F, Peng Z, Ye K, Yang X, Huang L, et al. Periostin enhances adipose-derived stem cell adhesion, migration, and therapeutic efficiency in Apo E deficient mice with hind limb ischemia. Stem Cell Res Ther. 2015;6:1\u201311.","journal-title":"Stem Cell Res Ther"},{"key":"3095_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-017-0735-7","volume":"9","author":"Z Yu","year":"2018","unstructured":"Yu Z, Cai Y, Deng M, Li D, Wang X, Zheng H, et al. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy 11 Medical and Health Sciences 1103 Clinical Sciences. Stem Cell Res Ther. 2018;9:1\u201314.","journal-title":"Stem Cell Res Ther"},{"key":"3095_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:1\u201315.","journal-title":"NPJ Regen Med"},{"key":"3095_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1089\/hum.2010.115","volume":"21","author":"P Charbord","year":"2010","unstructured":"Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther. 2010;21:1045\u201356.","journal-title":"Hum Gene Ther"},{"key":"3095_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/wrr.12415","volume":"24","author":"RJ Bodnar","year":"2016","unstructured":"Bodnar RJ, Satish L, Yates CC, Wells A. Pericytes: a newly recognized player in wound healing. Wound Repair Regen. 2016;24:204.","journal-title":"Wound Repair Regen"},{"key":"3095_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301\u201313.","journal-title":"Cell Stem Cell"},{"key":"3095_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/cells8091109","volume":"8","author":"G Chiaverina","year":"2019","unstructured":"Chiaverina G, di Blasio L, Monica V, Accardo M, Palmiero M, Peracino B, et al. Dynamic interplay between pericytes and endothelial cells during sprouting angiogenesis. Cells. 2019;8:1109.","journal-title":"Cells"},{"key":"3095_CR20","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1016\/j.celrep.2017.02.069","volume":"18","author":"T Yamazaki","year":"2017","unstructured":"Yamazaki T, Nalbandian A, Uchida Y, Li W, Arnold TD, Kubota Y, et al. Tissue myeloid progenitors differentiate into pericytes through TGF-\u03b2 signaling in developing skin vasculature. Cell Rep. 2017;18:2991\u20133004.","journal-title":"Cell Rep"},{"key":"3095_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ydbio.2017.05.001","volume":"427","author":"PH Dias Moura Prazeres","year":"2017","unstructured":"Dias Moura Prazeres PH, Sena IFG, Borges I da T, de Azevedo PO, Andreotti JPP, de Paiva AE, et al. Pericytes are heterogeneous in their origin within the same tissue. Dev Biol. 2017;427:6.","journal-title":"Dev Biol"},{"key":"3095_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03994-1","volume":"7","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Muramatsu M, Azuma E, Ikutani M, Nagai Y, Sagara H, et al. A subset of cerebrovascular pericytes originates from mature macrophages in the very early phase of vascular development in CNS. Sci Rep. 2017;7:1\u201316.","journal-title":"Sci Rep"},{"key":"3095_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/CH-189132","volume":"69","author":"A Blocki","year":"2018","unstructured":"Blocki A, Beyer S, Jung F, Raghunath M. The controversial origin of pericytes during angiogenesis\u2014implications for cell-based therapeutic angiogenesis and cell-based therapies. Clin Hemorheol Microcirc. 2018;69:215\u201332.","journal-title":"Clin Hemorheol Microcirc"},{"key":"3095_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/mt.2014.232","volume":"23","author":"A Blocki","year":"2015","unstructured":"Blocki A, Wang Y, Koch M, Goralczyk A, Beyer S, Agarwal N, et al. Sourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applications. Mol Ther. 2015;23:510\u201322.","journal-title":"Mol Ther"},{"key":"3095_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ncb1288","volume":"7","author":"S Song","year":"2005","unstructured":"Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005;7:870\u20139.","journal-title":"Nat Cell Biol"},{"key":"3095_CR26","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood-2004-01-0336","volume":"104","author":"I Rajantie","year":"2004","unstructured":"Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood. 2004;104:2084\u20136.","journal-title":"Blood"},{"key":"3095_CR27","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1167\/iovs.05-0309","volume":"46","author":"U Ozerdem","year":"2005","unstructured":"Ozerdem U, Alitalo K, Salven P, Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci. 2005;46:3502\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.trsl.2014.01.011","volume":"163","author":"A Geevarghese","year":"2014","unstructured":"Geevarghese A, Herman IM. Pericyte-endothelial cross-talk: implications and opportunities for advanced cellular therapies. Transl Res. 2014;163:296.","journal-title":"Transl Res"},{"key":"3095_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1083\/jcb.153.3.543","volume":"153","author":"M Hellstr\u00f6m","year":"2001","unstructured":"Hellstr\u00f6m M, Gerhardt H, Kal\u00e9n M, Li X, Eriksson U, Wolburg H, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol. 2001;153:543\u201353.","journal-title":"J Cell Biol"},{"key":"3095_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964\u20137.","journal-title":"Science"},{"key":"3095_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/sctm.16-0360","volume":"6","author":"RJ Medina","year":"2017","unstructured":"Medina RJ, Barber CL, Sabatier F, Dignat-George F, Melero-Martin JM, Khosrotehrani K, et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med. 2017;6:1316\u201320. https:\/\/doi.org\/10.1002\/sctm.16-0360.","journal-title":"Stem Cells Transl Med"},{"key":"3095_CR32","first-page":"97","volume":"2","author":"SN Usta","year":"2014","unstructured":"Usta SN, Scharer CD, Xu J, Frey TK, Nash RJ. Chemically defined serum-free and xeno-free media for multiple cell lineages. Ann Transl Med. 2014;2:97.","journal-title":"Ann Transl Med"},{"key":"3095_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40643-015-0063-7","volume":"2","author":"PW Hawkes","year":"2015","unstructured":"Hawkes PW. Fetal bovine serum: geographic origin and regulatory relevance of viral contamination. Bioresour Bioprocess. 2015;2:34.","journal-title":"Bioresour Bioprocess"},{"key":"3095_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s002620050614","volume":"49","author":"A Mackensen","year":"2000","unstructured":"Mackensen A, Dr\u00e4ger R, Schlesier M, Mertelsmann R, Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother. 2000;49:152\u20136.","journal-title":"Cancer Immunol Immunother"},{"key":"3095_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10616-013-9633-8","volume":"65","author":"G Gstraunthaler","year":"2013","unstructured":"Gstraunthaler G, Lindl T, Van Der Valk J. A plea to reduce or replace fetal bovine serum in cell culture media. Cytotechnology. 2013;65:791\u20133.","journal-title":"Cytotechnology"},{"key":"3095_CR36","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/scd.2012.0415","volume":"22","author":"A Blocki","year":"2013","unstructured":"Blocki A, Wang Y, Koch M, Peh P, Beyer S, Law P, et al. Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev. 2013;22:2347\u201355.","journal-title":"Stem Cells Dev"},{"key":"3095_CR37","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.3390\/ijms19102913","volume":"19","author":"S Beyer","year":"2018","unstructured":"Beyer S, Koch M, Lee YH, Jung F, Blocki A. An in vitro model of angiogenesis during wound healing provides insights into the complex role of cells and factors in the inflammatory and proliferation phase. Int J Mol Sci. 2018;19:2913.","journal-title":"Int J Mol Sci"},{"key":"3095_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","volume":"1180","author":"AT Feldman","year":"2014","unstructured":"Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014;1180:31\u201343.","journal-title":"Methods Mol Biol"},{"key":"3095_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/10520293309116112","volume":"8","author":"NC Foot","year":"2009","unstructured":"Foot NC, Chandler N. The masson trichrome staining methods in routine laboratory use. Stain Technol. 2009;8:101\u201310. https:\/\/doi.org\/10.3109\/10520293309116112.","journal-title":"Stain Technol"},{"key":"3095_CR40","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1021\/jp5077559","volume":"119","author":"JY Dewavrin","year":"2015","unstructured":"Dewavrin JY, Abdurrahiem M, Blocki A, Musib M, Piazza F, Raghunath M. Synergistic rate boosting of collagen fibrillogenesis in heterogeneous mixtures of crowding agents. J Phys Chem B. 2015;119:4350\u20138.","journal-title":"J Phys Chem B"},{"key":"3095_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2011.03.003","volume":"63","author":"C Chen","year":"2011","unstructured":"Chen C, Loe F, Blocki A, Peng Y, Raghunath M. Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies. Adv Drug Deliv Rev. 2011;63:277\u201390.","journal-title":"Adv Drug Deliv Rev"},{"key":"3095_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41550","volume":"7","author":"PA Tebebi","year":"2017","unstructured":"Tebebi PA, Kim SJ, Williams RA, Milo B, Frenkel V, Burks SR, et al. Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"3095_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1189\/jlb.4MR0316-102R","volume":"100","author":"LA DiPietro","year":"2016","unstructured":"DiPietro LA. Angiogenesis and wound repair: when enough is enough. J Leukoc Biol. 2016;100:979.","journal-title":"J Leukoc Biol"},{"key":"3095_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874226200902010079","volume":"2","author":"JE Beliz\u00e1rio","year":"2009","unstructured":"Beliz\u00e1rio JE. Immunodeficient mouse models: an overview. Open Immunol J. 2009;2:79\u201385.","journal-title":"Open Immunol J"},{"key":"3095_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics14020381","volume":"14","author":"R Alvites","year":"2022","unstructured":"Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maur\u00edcio AC. Mesenchymal stem\/stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics. 2022;14:381.","journal-title":"Pharmaceutics"},{"issue":"22","key":"3095_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/1874325001105010242","volume":"5","author":"R Mafi","year":"2011","unstructured":"Mafi R, Hindocha S, Mafi P, Griffin M, Khan WS. Sources of adult mesenchymal stem cells applicable for musculoskeletal applications\u2014a systematic review of the literature. Open Orthop J. 2011;5(22):242\u20138.","journal-title":"Open Orthop J"},{"key":"3095_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genov\u00e9 G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193\u2013215.","journal-title":"Dev Cell"},{"key":"3095_CR48","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008;8:618\u201331.","journal-title":"Nat Rev Cancer"},{"key":"3095_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10571-017-0549-2","volume":"38","author":"PHDM Prazeres","year":"2018","unstructured":"Prazeres PHDM, Almeida VM, Lousado L, Andreotti JP, Paiva AE, Santos GSP, et al. Macrophages generate pericytes in the developing brain. Cell Mol Neurobiol. 2018;38:777.","journal-title":"Cell Mol Neurobiol"},{"key":"3095_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00953-2","volume":"8","author":"K Krishnasamy","year":"2017","unstructured":"Krishnasamy K, Limbourg A, Kapanadze T, Gamrekelashvili J, Beger C, H\u00e4ger C, et al. Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia. Nat Commun. 2017;8:1\u201314.","journal-title":"Nat Commun"},{"key":"3095_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood-2009-12-257832","volume":"116","author":"A Fantin","year":"2010","unstructured":"Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood. 2010;116:829.","journal-title":"Blood"},{"key":"3095_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01591-0","volume":"11","author":"L Beltran-Camacho","year":"2020","unstructured":"Beltran-Camacho L, Jimenez-Palomares M, Rojas-Torres M, Sanchez-Gomar I, Rosal-Vela A, Eslava-Alcon S, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11:1\u201320.","journal-title":"Stem Cell Res Ther"},{"key":"3095_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0871-8","volume":"9","author":"R Berndt","year":"2018","unstructured":"Berndt R, Hummitzsch L, He\u00df K, Albrecht M, Zitta K, Rusch R, et al. Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach. Stem Cell Res Ther. 2018;9:1\u201317.","journal-title":"Stem Cell Res Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03095-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T09:08:09Z","timestamp":1668676089000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03095-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03095-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments and use of human blood samples were approved by local regulatory authorities.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}